Paraparesis, Tropical Spastic clinical trials
The registry lists 23 studies for Paraparesis, Tropical Spastic across 6 countries. 2 are recruiting or about to start. 19 of them are mainly about Paraparesis, Tropical Spastic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.
Get an email when these change. Save the Paraparesis, Tropical Spastic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institute of Neurological Disorders and Stroke (NINDS) (6) · MP Biomedicals, LLC (3) · Imperial College London (3) · Hospital Universitário Professor Edgard Santos (2) · Kyowa Kirin Co., Ltd. (1) · Mitsubishi Tanabe Pharma Corporation (1) · St. Marianna University School of Medicine (1) · Universidad Peruana Cayetano Heredia (1)
What is being tested here
Drugs under test in Paraparesis, Tropical Spastic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Who these studies take
Of the 2 Paraparesis, Tropical Spastic studies recruiting now, 1 (50%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (50%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 2 (100%) | 2 (100%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 2 (100%) | 2 (100%) |
| 75 | 2 (100%) | 2 (100%) |
| 85 | 2 (100%) | 2 (100%) |
Across all 23 studies, recruiting or not: 22% stop at 75 or younger and 0% at 65; 22% take children; 0% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 23 of 23. search them.
- Evaluation of Patients With HAM/TSPRecruitingNCT000017781 country
- Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 InfectionRecruitingNCT07555431Phase 21 country
- Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)TerminatedNCT01343355Phase 2/31 country
- A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)CompletedNCT05240612Phase 11 country
- Raltegravir for HAM/TSPCompletedNCT01867320Early Phase 11 country
- Rituximab for HTLV-1-associated MyelopathyStatus unknownNCT04004819Phase 21 country
- A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)TerminatedNCT03191526Phase 31 country
- Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)CompletedNCT00773292Phase 2/31 country
- Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised TrialCompletedNCT00272480Phase 2/31 country
- Rehabilitation in Patients With Human Lymphotropic Virus Type IStatus unknownNCT04875403Not applicable1 country
- Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic ParaparesisCompletedNCT00076843Phase 11 country
- Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 InfectionCompletedNCT02655471Early Phase 11 country
- Urological Physical Therapy in HTLV-1 With Urinary SymptomsCompletedNCT01651819Not applicable1 country
- MP Diagnostics HTLV Blot 2.4 Post-Market Clinical StudyCompletedNCT03226119Phase 41 country
- Assessment of Patients With Multiple Sclerosis (MS)CompletedNCT000011561 country
- Dual Algorithm Post Market Clinical StudyCompletedNCT031460131 country
- Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)CompletedNCT00681980Phase 31 country
- Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) DiseasesCompletedNCT01472263Phase 31 country
- The HAM Infliximab StudyTerminatedNCT00823641Phase 21 country
- Evaluation of the MP Diagnostics HTLV Blot 2.4Status unknownNCT014670241 country
- MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic ParaparesisCompletedNCT000347231 country
- Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)CompletedNCT00001785Phase 21 country
- Safety and Efficiency Study of Valproic Acid In HAM/TSPTerminatedNCT00519181Not applicable